Robotic Exoskeleton Gets First-Ever FDA Approval
The ReWalk exoskeleton allows some people paralyzed from the waist down to walk again, with the aid of crutches. Dina Fine Maron reports
By Dina Fine Maron
SUBSCRIBE TO 60-Second Health
On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
It’s all in the wrist. That’s the location of the wireless remote control for the first wearable exoskeleton to be approved by the FDA for home use. It’s called ReWalk.
Some people paralyzed from the waist down can use the robotic apparatus to walk again, with the aid of crutches.
Produced by Argo Medical Technologies, ReWalk consists of leg braces, motorized joints and motion sensors that correct for changes in balance and movement. A harness keeps the suit in place on the user, who wears a backpack holding the rechargeable battery power supply and controlling computer.
ReWalk was created by Argo’s founder, Amit Goffer, himself quadriplegic as the result of a 1997 ATV accident. Goffer holds a doctorate in electrical and computer engineering.
The device is for people who can already stand with the assistance of crutches or a walker. It weighs about 46 pounds. But Argo says that a user only feels the weight of the roughly five-pound backpack.
The green light from the FDA is a big step forward for the entire exoskeleton industry. The price for a unit is $69,500. But the value of such devices may be beyond evaluation.
—Dina Fine Maron
[The above text is a transcript of this podcast.]
Subscribe to Support Independent Journalism
Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.
When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.
Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber
